Science Corp’s PRIMA wins EU CE mark, BCI restores central vision
Science Corp secured CE marking for its PRIMA retinal implant, making it the first BCI device approved in Europe to restore functional central vision to patients with geographic atrophy from age‑related macular degeneration. The approval opens commercial rollout across 30 EU countries, with initial implants slated for Germany, and the company is pursuing FDA clearance in the US.